Balloon pulmonary angioplasty (BPA) is an emerging treatment for patients with inoperable
chronic thromboembolic pulmonary hypertension (CTEPH). We report on a prospective …

Background Aim of this prospective study was to evaluate the effects of exercise training in
patients with inoperable or residual chronic thromboembolic pulmonary hypertension (CTEPH…

In the 2009 European Guidelines on the diagnosis and treatment of pulmonary hypertension
(PH), one section covers aspects of pathophysiology, diagnosis and treatment of chronic …

Riociguat is the treatment of choice for inoperable patients with chronic thromboembolic
pulmonary hypertension (CTEPH). We addressed here whether additional balloon pulmonary …

慢性血栓栓塞的聚氨酯lmonary hypertension (CTEPH) is a subgroup of pulmonary
hypertension that differs from all other forms of PH in terms of its pathophysiology, patient …

Objective: Pulmonary endarterectomy (PEA) is the standard therapy for patients with chronic
thromboembolic pulmonary hypertension (CTEPH). In the immediate postoperative period, …

The objective of this prospective study was to assess the prevalence of anxiety and depression
disorders and their association with quality of life (QoL), clinical parameters and survival …

Background Pulmonary endarterectomy (PEA) is a curative treatment option for more than
60% of patients with chronic thromboembolic pulmonary hypertension (CTEPH). For selected …

Background The incidence of chronic thromboembolic pulmonary hypertension (CTEPH) is
unknown. Previous studies from the United Kingdom and Spain have reported incidence …

Symptomatic patients with chronic thromboembolic disease (CTED) without pulmonary
hypertension often show an excessive increase in mean pulmonary arterial pressure (MPAP) …